AstraZeneca in $6.9bn cancer deal with Daiichi Sankyo
Pharma companies to share drug development and commercialisation costs as well as profits…
Pharma companies to share drug development and commercialisation costs as well as profits…
Chinese telecom group weathers criticism from Washington with strong overseas growth…
Some in the bloc favour Britain’s early departure, others hope for second referendum…
What started as a seemingly small affair has rapidly expanded to become one of the biggest money laundering scandals of all time…
The $927bn of deals in quarter marks second strongest start to year since millennium…
UK’s last investment bank with global ambitions set for another period of uncertainty…
Booming smartphone sales bolster Chinese telecoms maker amid spat with Washington…
Half of the German company’s revenues come from partners but at some of them there is a mismatch with the reality on the ground…
Move to counter foreign interference will hit pan-European election campaigning…